Literature DB >> 8623865

Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium.

T Widrich1, L D Bradley, A R Mitchinson, R L Collins.   

Abstract

OBJECTIVE: Intrauterine infusion of saline solution during transvaginal ultrasonography enhances visualization of the endometrium. We compared the accuracy and pain rating of saline infusion sonography with those of flexible office hysteroscopy. STUDY
DESIGN: The uterine cavities of 130 patients with abnormal bleeding were evaluated by two physicians in an office setting. Findings of endometrial polyps, submucous myomas, synechiae, endometrial hyperplasia, or cancer were recorded independently and subsequently compared. Patients rated their pain after each procedure.
RESULTS: Both procedures were performed in 113 of 130 patients. With saline infusion sonography pathologic findings were identified in 61 patients (54%). For all findings combined, sensitivity was 0.96 and specificity was 0.88, compared with hysteroscopy. The results of saline infusion sonography and hysteroscopy did not differ significantly (p = 0.18). The former was less painful for patients than hysteroscopy (p < 0.0001).
CONCLUSION: Saline infusion sonography is an accurate and well-tolerated method to evaluate abnormal uterine bleeding, compared with hysteroscopy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623865     DOI: 10.1016/s0002-9378(96)70680-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  A new diagnostic test for endometrial cancer?: Cytology analysis of sonohysterography distention media.

Authors:  Onur Guralp; Susan M Sheridan; Josephine Harter; James Louis Hinshaw; Songwon Seo; Ellen M Hartenbach; Steven Lindheim; Sarah Stewart; David M Kushner
Journal:  Int J Gynecol Cancer       Date:  2013-09       Impact factor: 3.437

2.  Letter to Editor.

Authors:  M K Tangri
Journal:  Med J Armed Forces India       Date:  2015-07

3.  Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013

4.  Office Hysteroscopy: An Insight.

Authors:  B S Duggal; P Tarneja; R D Wadhwa; S K Rath
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Prospective Study of Saline Infusion Sonography and Office Hysteroscopy.

Authors:  S Rudra; B S Duggal; D Bharadwaj
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Diagnostic value of saline contrast sonohysterography comparing with hysteroscopy for detecting endometrial abnormalities in women with abnormal uterine bleeding.

Authors:  Mohammad Ali Karimzadeh; Razieh Dehghani Firouzabadi; Farzaneh Goharzad
Journal:  Iran J Reprod Med       Date:  2011

Review 7.  Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions.

Authors:  Lotte L Nieuwenhuis; Frederik Jr Hermans; A J Marjolein Bij de Vaate; Mariska Mg Leeflang; Hans Am Brölmann; Wouter Jk Hehenkamp; Ben Willem J Mol; T Justin Clark; Judith Af Huirne
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

8.  Diagnostic hysteroscopy and saline infusion sonography in the diagnosis of intrauterine abnormalities: an assessment of patient preference.

Authors:  Heleen van Dongen; Anne Timmermans; Cathrien E Jacobi; Trudy Elskamp; Cor D de Kroon; Frank Willem Jansen
Journal:  Gynecol Surg       Date:  2010-12-30

9.  Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.

Authors:  M B Marttunen; B Cacciatore; P Hietanen; S Pyrhönen; A Tiitinen; T Wahlström; O Ylikorkala
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

10.  Cancer of the endometrium: current aspects of diagnostics and treatment.

Authors:  Karsten Münstedt; Phillip Grant; Joachim Woenckhaus; Gabriele Roth; Hans-Rudolf Tinneberg
Journal:  World J Surg Oncol       Date:  2004-07-21       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.